Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.

BCNU (carmustine), VM26 (teniposide) and ARA-A5'P (vidarabin-monophosphate) were compared in their activity against 30 cell lines of primary (N = 21) and metastatic (N = 9) human brain tumours, which were characterized in tissue culture by cytochemical, immunological and cytogenetic criteria. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdahn, U., Zapf, J., Weber, H., Dünisch, G., Löbering, H. G., Martin, R., Mertens, H. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1987
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002094/
https://www.ncbi.nlm.nih.gov/pubmed/2434122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002094/
https://www.ncbi.nlm.nih.gov/pubmed/2434122

Ejemplares similares